Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05193981 · ClinicalTrials.gov registry record

A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD

A clinical trial of Autosomal Dominant Polycystic Kidney Disease, sponsored by Mayo Clinic.

Active
Registry status
80
Enrollment target
1
Study location

NCT05193981 is a study of Autosomal Dominant Polycystic Kidney Disease that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 153-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05193981, a study of Autosomal Dominant Polycystic Kidney Disease, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess homocysteine metabolism and systemic endothelial function at the early stages of the disease and determine the prognostic value of homocysteine, related metabolites, and markers of endothelial function and injury to estimate renal disease severity and progression in patients with early Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Conditions Studied

Autosomal Dominant Polycystic Kidney Disease

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-09-14
Est. Completion 2026-06

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05193981

The ClinicalTrials.gov registry entry for NCT05193981 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 153-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (48% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autosomal Dominant Polycystic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.

NCT05193981 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05193981 about?

NCT05193981 is a clinical study titled "A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD". The purpose of this study is to assess homocysteine metabolism and systemic endothelial function at the early stages of the disease and determine the prognostic value of homocysteine, related metabolites, and markers of endothelial function and injury to estimate renal disease severity and progressi...

What is the current status of trial NCT05193981?

This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2021-09-14. Estimated completion is 2026-06.

What conditions does trial NCT05193981 study?

This clinical trial studies the following conditions: Autosomal Dominant Polycystic Kidney Disease.

Who is sponsoring clinical trial NCT05193981?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05193981 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autosomal Dominant Polycystic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autosomal Dominant Polycystic Kidney Disease

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.